<DOC>
	<DOCNO>NCT02343094</DOCNO>
	<brief_summary>The purpose study determine whether sodium phenylbutyrate reduce Lcn2 urinary expression proteinuric patient .</brief_summary>
	<brief_title>Phenylbutyrate Proteinuric Nephropathies</brief_title>
	<detailed_description>Proteinuria major prognosis factor chronic kidney disease ( CKD ) progression . Convergent evidence clinical experimental study indicate albuminuria proteinuria simply marker CKD progression , active player evolution disease . Mechanistically , show proteinuria induces endoplasmic reticulum stress tubular cell , lead induction lipocalin 2/NGAL , critical element CKD progression . Moreover , proteinuric mouse treat phenylbutyrate protect CKD progression . The aim study evaluate efficacy phenybutyrate , molecular chaperone inhibits ER stress , proteinuria-induced NGAL expression . Urinary NGAL/creatinine ratio evaluate proteinuric patient treatment phenylbutyrate .</detailed_description>
	<mesh_term>4-phenylbutyric acid</mesh_term>
	<criteria>Chronic Kidney disease ore 3 month Proteinuria &gt; 1g/d 0,1g/mmmol creatinine eGFR &gt; 30ml/mn/1,73m2 write informed consent affiliate social security health insurance Women childbearing potential Recent ( &lt; 3 month ) modification ACE inhibitor ARB Acute renal failure eGFR &lt; 30ml/mn/1,73m2 Nephrotic syndrome ( albumin√©lia &lt; 30g/l ) Infection HIV , HCV , HBV Liver insufficiency No affiliate social security health insurance inclusion another protocol biomedical research risk nonadherence protocol visit patient cardiac insufficiency grade 3 4 patient require strict saltfree diet patient corticoid immunosuppresseurs clinical intolerance treatment intolerance fructose , syndrome malabsorption glucose galactose deficit sucrase / isomaltase patient treat Probenecide</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Proteinuria</keyword>
	<keyword>Lipocalin 2</keyword>
	<keyword>Neutrophil gelatinase associate lipocalin</keyword>
	<keyword>ELISA</keyword>
</DOC>